Author: Williams, Phoebe C.M.; Howard-Jones, Annaleise R.; Hsu, Peter; Palasanthiran, Pamela; Gray, Paul E.; McMullan, Brendan J.; Britton, Philip N.; Bartlett, Adam W.
Title: SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings Cord-id: sub5iulv Document date: 2020_8_19
ID: sub5iulv
Snippet: As the SARS-CoV-2 pandemic unfolds across the globe, consistent themes are emerging with regard to aspects of SARS-CoV-2 infection and its associated disease entities in children. Overall, children appear to be less frequently infected by, and affected by, SARS-CoV-2 virus and the clinical disease COVID-19. Large epidemiological studies have revealed children represent less than 2% of the total confirmed COVID-19 cases, of whom the majority experience minimal or mild disease that do not require
Document: As the SARS-CoV-2 pandemic unfolds across the globe, consistent themes are emerging with regard to aspects of SARS-CoV-2 infection and its associated disease entities in children. Overall, children appear to be less frequently infected by, and affected by, SARS-CoV-2 virus and the clinical disease COVID-19. Large epidemiological studies have revealed children represent less than 2% of the total confirmed COVID-19 cases, of whom the majority experience minimal or mild disease that do not require hospitalisation. Children do not appear to be major drivers of SARS-CoV-2 transmission, with minimal secondary virus transmission demonstrated within families, schools and community settings. There are several postulated theories regarding the relatively low SARS-CoV-2 morbidity and mortality seen in children, which largely relate to differences in immune responses compared to adults, as well as differences in angiotensin converting enzyme 2 distribution that potentially limits viral entry and subsequent inflammation, hypoxia and tissue injury. The recent emergence of a multisystem inflammatory syndrome bearing temporal and serological plausibility for an immune-mediated SARS-CoV-2-related disease entity is currently under investigation. This article summarises the current available data regarding SARS-CoV-2 and the paediatric population, including the spectrum of disease in children, the role of children in virus transmission, and host-virus factors that underpin the unique aspects of SARS-CoV-2 pathogenicity in children.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and adolescent child: 1
- acute ards respiratory distress syndrome and long period: 1, 2
- acute ards respiratory distress syndrome and long term morbidity: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and long term outcome: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and long term prognosis: 1
- acute ards respiratory distress syndrome and long term respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute ards respiratory distress syndrome and low prevalence: 1, 2
- acute ards respiratory distress syndrome and low protein: 1, 2, 3, 4
- acute ards respiratory distress syndrome and low remain: 1
- acute ards respiratory distress syndrome and low respiratory tract: 1, 2
- acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- acute ards respiratory distress syndrome and lung microenvironment: 1, 2, 3, 4
- acute ards respiratory distress syndrome and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and macrophage activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute ards respiratory distress syndrome feature and lung injury: 1
- acute illness and admission level: 1
- acute illness and adolescent child: 1
- acute illness and long period: 1, 2
- acute illness and long term morbidity: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date